NBIX
NASDAQStockNeurocrine Biosciences, Inc.
$128.03-1.51 (-1.17%)
52-Week Range
$87.54
$155.63
Key Stats
Market Cap
12.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.36
Volume
457.7K
Avg Volume
1.0M
Performance
1M
-7.03%
3M
-17.06%
6M
-9.01%
YTD
-9.12%
1Y
+17.24%
3Y
+33.83%
5Y
+31.64%
Price Chart
ETF Exposure
NBIX is held by 216 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| CFO | VictoryShares US 500 Enhanced Volatility Wtd ETF | 0.15% |
| PINK | Simplify Health Care ETF | 0.14% |
| CVMC | Calvert US Mid-Cap Core Responsible Index ETF | 0.13% |
| FNDA | Schwab Fundamental U.S. Small Company Index ETF | 0.13% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.12% |
| FTQI | First Trust Nasdaq BuyWrite Income ETF | 0.12% |
| FMDE | FIDELITY ENHANCED MID CAP ETF | 0.11% |
| DEUS | Xtrackers Russell US Multifactor ETF | 0.11% |
| QUS | State Street SPDR MSCI USA StrategicFactors ETF | 0.10% |
| AMCA | iShares Russell 1000 Pure U.S. Revenue ETF | 0.10% |
| IWR | iShares Russell Mid-Cap ETF | 0.10% |
| REMC | Columbia Research Enhanced Mid Cap ETF | 0.10% |
| GARP | iShares MSCI USA Quality GARP ETF | 0.10% |
| RWK | Invesco S&P MidCap 400 Revenue ETF | 0.10% |
| ONEO | State Street SPDR Russell 1000 Momentum Focus ETF | 0.09% |
| HEQQ | JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF | 0.09% |
| MIDU | Direxion Daily Mid Cap Bull 3X ETF | 0.09% |
| PTL | Inspire 500 ETF | 0.09% |
| EQAL | Invesco Russell 1000 Equal Weight ETF | 0.07% |
| HELO | JPMorgan Hedged Equity Laddered Overlay ETF | 0.07% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.07% |
| DFUV | Dimensional - US Marketwide Value ETF | 0.07% |
| JUSA | JPMorgan U.S. Research Enhanced Large Cap ETF | 0.07% |
| CDEI | Calvert US Large-Cap Diversity, Equity And Inclusion Index ETF | 0.06% |
| USXF | iShares ESG Advanced MSCI USA ETF | 0.06% |
| SCHG | Schwab U.S. Large-Cap Growth ETF | 0.05% |
| GGUS | Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF | 0.04% |
| SHE | State Street SPDR MSCI USA Gender Diversity ETF | 0.04% |
| BALI | iShares U.S. Large Cap Premium Income Active ETF | 0.04% |
| USSG | Xtrackers MSCI USA Selection Equity ETF | 0.04% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.04% |
| SUSL | iShares ESG MSCI USA Leaders ETF | 0.04% |
| IUSG | iShares Core S&P U.S. Growth ETF | 0.04% |
| JHML | John Hancock Investments - Multifactor Large Cap ETF | 0.04% |
| VONG | Vanguard Russell 1000 Growth ETF | 0.04% |
| IWF | iShares Russell 1000 Growth ETF | 0.04% |
| QWLD | State Street SPDR MSCI World StrategicFactors ETF | 0.04% |
| NZUS | State Street SPDR MSCI USA Climate Paris Aligned ETF | 0.03% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.03% |
| STXG | Strive 1000 Growth ETF | 0.03% |
| DXUV | Dimensional - US Vector Equity ETF | 0.03% |
| IALT | iShares Systematic Alternatives Active ETF | 0.03% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.03% |
| AVLC | Avantis U.S. Large Cap Equity ETF | 0.03% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.03% |
| FLSP | Franklin Systematic Style Premia ETF | 0.03% |
| QARP | Xtrackers Russell 1000 US Quality at a Reasonable Price ETF | 0.03% |
| CVLC | Calvert US Large-Cap Core Responsible Index ETF | 0.03% |
| ENHU | iShares Enhanced Large Cap Core Active ETF | 0.03% |
| AVUS | Avantis U.S. Equity ETF | 0.03% |
About NBIX ETF Exposure
Neurocrine Biosciences, Inc. (NBIX) is held by 216 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 12.8B, NBIX is a widely held institutional stock. The stock currently trades at $128.03. Investors can gain exposure to NBIX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NBIX, sorted by portfolio weight.